Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or

Clinical Trial Description

The purpose of this study was to evaluate the safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusive lesions compare with conventional venous stent. ;

Study Design

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05622500` - Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease	N/A
Recruiting	`NCT04694248` - Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting	N/A
Completed	`NCT05324787` - Treatment of Vein Stenosis or Occlusion With the Oblique Stent	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT05622500 - Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease

N/A

Recruiting

NCT04694248 - Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

N/A

Completed

NCT05324787 - Treatment of Vein Stenosis or Occlusion With the Oblique Stent

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04812444
Study type	Interventional
Source	Zhejiang Zylox Medical Device Co., Ltd.
Contact
Status	Completed
Phase	N/A
Start date	October 9, 2020
Completion date	October 20, 2023

Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms